US 10323083
Agents that specifically bind matrilin-3 and their use
granted A61KA61K2039/505A61K47/6811
Quick answer
US patent 10323083 (Agents that specifically bind matrilin-3 and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 98
- CPC classes
- A61K, A61K2039/505, A61K47/6811, A61K47/6843